Erratum: Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: Guideline from the college ofamerican pathologists, international association for the study of lung cancer, and association for molecular pathology (The Journal of Molecular Diagnostics (2013) 15 (415-453))

摘要

In the article entitled, "Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyro-sine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology" (Volume 15, pages 415-453 of the July 2013 issue), Table 4 and Supplemental Table S5 contained errors. These analyses failed to distinguish between European Spanish and Latin American (Hispanic) populations. Re-analysis of the four studies originally cited as providing data for Latin American (Hispanic) populations led to the re-categorization of 369 patients, with only 3 remaining Latin American (Hispanic) patients, a population too limited for meaningful analysis.